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 ABSTRACT 
 
Damage to the optic nerve (optic neuropathy) can result in permanent loss 
of vision or blindness through retinal ganglion cell (RGC) death. Our prior work 
identified a burst of superoxide anion as a critical molecular event in RGCs prior 
to injury-induced cell death. Recently, Suarez-Moreira et al (JACS 131:15078, 
2009) demonstrated that vitamin B12 scavenges superoxide as effectively as 
superoxide dismutase. Vitamin B12 deficiency can lead to optic neuropathy through 
unknown mechanisms. We investigated the relationship between superoxide 
scavenging by cyanocobalamin, the most abundant vitamin B12 vitamer, and its 
neuroprotective properties in neuronal cells.  
Cyanocobalamin at concentrations of 10 µM and 100 µM reduced the rate 
of superoxide generation by 34% and 79% in cell free assays, respectively. In 
menadione-treated RGC-5 cells, cyanocobalamin concentrations above 10 nM 
scavenged superoxide anion similar to those treated with pegylated-SOD. 
Cyanocobalamin at concentrations of 100 µM and 1 mM reduced RGC-5 cell 
death from menadione by 20% and 32%, respectively. In rats with unilateral optic 
nerve transection, a single intravitreal dose of 667 µM cyanocobalamin 
significantly reduced the number of RGCs with superoxide. This dose also 
increased RGC survival rate compared to rats injected with saline control.  
These data suggest that vitamin B12 may be an important neuroprotectant, 
which could cause death of RGCs when depleted in nutritional deficiency. Vitamin 
B12 could also potentially be used as a therapy to slow progression of RGC death 
in patients with optic neuropathies characterized by overproduction of superoxide.  
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 RÉSUMÉ 
 
Les dommages au nerf optique (neuropathie optique) peuvent entraîner la 
perte permanente de la vision ou la cécité causée par la mort des 
cellules ganglionnaires de la rétine (CGR). Nous avons identifié qu’une 
surproduction de l'anion superoxyde constitue un événement moléculaire critique 
précédant la mort cellulaire induite par des lésions. Récemment, Suarez-Moreira et 
al (JACS 131:15078, 2009) ont démontré que la vitamine B12 peut capter l’anion 
superoxyde aussi efficacement que l’enzyme superoxyde dismutase. La carence en 
vitamine B12 peut conduire à une neuropathie optique causée par des 
mécanismes inconnus. Nous avons étudié la relation entre la captation de 
superoxyde par la cyanocobalamine (forme de vitamine B12 la plus abondante) et 
ses propriétés neuroprotectrices dans les cellules neuronales. 
La cyanocobalamine aux concentrations de 10 µM et 100 µM a réduit le 
taux de production de superoxyde respectivement par 34% et 79% dans les 
essais sans-cellule. Dans les cellules RGC-5 traités avec la ménadione, les 
concentrations de cyanocobalamine supérieures à 10 nM ont diminué l’anion 
superoxyde à des valeurs similaires à celles traitées par PEG-SOD. La 
cyanocobalamine aux concentrations de 100 µM et 1 µM a réduit la mort des 
cellules RGC-5 exposées à la ménadione par 20% et 32%, respectivement. Chez 
les rats avec section du nerf optique unilatérale, une dose intravitréenne de 667 µM 
de cyanocobalamine a réduit le nombre de CGRs exposées au superoxyde. Cette 
dose a également augmenté le taux de survie des CGRs comparativement aux 
rats injectés avec la solution témoin. Ces données suggèrent que la vitamine B12 
 peut être un neuroprotecteur important, et sa carence nutritionnelle pourrait causer 
la mort de CGRs. La vitamine B12 pourrait aussi potentiellement être utilisée 
comme une thérapie pour ralentir la progression de la mort CGR chez les patients 
avec les neuropathies optiques caractérisés par une surproduction de superoxyde.  
 
Mots Clés : La vitamine B12, l'anion superoxyde, neuropathie optique, la 
neuroprotection 
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I. INTRODUCTION 
 
Vision is arguably the most important of the five senses, and the sensory 
modality that is most easily taken for granted. There is hardly a task we do in our 
daily lives that does not require sight. The visual system is composed of the eye, 
the retina, the optic nerve, and the brain. Light passes through the anterior chamber 
and lens of the eye, and focuses on the retina. The retina converts the light stimuli 
into electrical signals, which are then sent through the optic nerve to processing 
centers in the brain for vision (the lateral geniculate nucleus and then the visual 
cortex), pupillary responses (pretectal nuclei), sleep-wake cycling 
(suprachiasmatic nucleus of the hypothalamus), and orientation in space (superior 
colliculus). While this sounds deceptively simple, there is actually a tremendous 
amount of complex cellular interactions in the retina and the brain that allow us to 
perceive our visually complex environment. Abnormalities, whether genetic, 
molecular, cellular, or anatomical anywhere in the visual system will often cause 
disruptions in vision. While all the structures of the visual system are critical for 
normal vision, the focus of this thesis will be on the retina and the optic nerve.  
 
1.1 The Retina and Optic Nerve 
The retina is the translucent sensory layer of the eye responsible for 
transmitting visual stimuli to the brain. The retina itself is also organized into 
layers: starting from the outer retina are the photoreceptor (rods and cones) 
phototransduction elements, the outer nuclear layer containing the photoreceptor 
nuclei, the outer plexiform (synaptic) layer, the inner nuclear layer, the inner 
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plexiform layer, the ganglion cell layer, and the nerve fibre layer. When light is 
focused onto the retina, it must first reach the photoreceptors (rods and cones), 
located in the outermost layer of the retina, right next to the retinal pigment 
epithelium (RPE) (Kandel et al., 2000). The photoreceptors transform this light 
stimulus into an electrical signal that is then transmitted to bipolar, horizontal, and 
amacrine cells for refinement before finally reaching the retinal ganglion cells 
(RGCs). Since the light-sensitive photoreceptor cells are in the outermost layer, 
the axons of RGCs are unmyelinated in most species so that they remain 
translucent for light to pass through. 
The RGC axons converge to form the optic nerve. In vertebrate retinas, a 
‘blind spot’ arises from where the RGC axons exit the retina due to the lack of 
retinal cells in the optic disc area (Kandel et al., 2000). The optic nerve is 
responsible for transmitting action potentials from the RGCs to the brain. Up until 
the lamina cribrosa, the axons of the optic nerve are unmyelinated, requiring an 
abundance of mitochondria to propel the action potential and restore membrane 
potential (Waxman, 1978, Carelli et al., 2004). The axons of the optic nerve 
become myelinated after passing through the lamina cribrosa and capable of 
saltatory conduction, requiring less mitochondria. Before reaching their targets in 
the brain, the optic nerve of each eye converge to form the optic chiasm, 
approximately 50 mm behind the eye in humans. In primates, RGC axons from the 
nasal half of the retina cross-over at the optic chiasm to join the contralateral 
retina’s temporal RGC axons in the optic tract, before continuing towards the 
lateral geniculate nucleus (Kandel et al., 2000). RGC axons from the temporal half 
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of the retina do not cross-over at the optic chiasm. In rodents, most of the axons 
from one eye cross over to the opposite optic tract. 
 
1.2 Optic Neuropathies 
When the optic nerve is afflicted by injury or disease, it signals the RGC 
soma to activate a programmed cell death pathway (apoptosis). Much like the 
brain, the neurons of the retina are not able to regenerate, resulting in irreversible 
vision loss, or an optic neuropathy. Optic neuropathies are the leading cause of 
blindness worldwide, with glaucoma being the most prevalent (Quigley, 1996). In 
the United States alone, an estimated 2.2 million people are currently affected by 
glaucoma (Quigley and Broman, 2006, Dirani et al., 2011), the prevalence of 
which is expected to increase with the aging population. Optic neuropathies can 
arise from several etiologies. Some examples include abnormalities of the lamina 
cribrosa (Quigley and Addicks, 1981), ischemia (Selles-Navarro et al., 1996), 
inflammation (Trip et al., 2005), or trauma (Steinsapir, 1999).  
The lamina cribrosa is a multilayered network of collagen fibres located 
behind the optic disc, through which the optic nerve exits the eye. Since the optic 
nerve passes through the lamina cribrosa on its journey to the brain, abnormalities 
in structure or composition can lead to injury to the optic nerve. Individuals with 
glaucoma appear to have compression of lamina cribrosa sheets and eventual 
backward bowing of the entire structure. This is believed to compress the optic 
nerve from the superior and inferior poles and damage RGC axons (Quigley and 
Addicks, 1981, Quigley et al., 1983). Ischemia occurs when there is limited or a 
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lack of blood supply to tissues, causing oxygen and nutrient deprivation. In cases 
of ischemic optic neuropathy, the RGC soma die from lack of oxygen and other 
required trophic factors the blood supply provides. Optic neuropathies can also 
arise from inflammation of the optic nerve as a result of infection or autoimmune 
diseases. Trauma causes RGC death by direct traumatic damage or severing of 
RGC axons 
Though often overlooked, deficiencies of critical vitamins and nutrients 
can also lead to vision problems (Whatham et al., 2008). A well known example of 
this is vitamin A deficiency causing visual impairment during dim lighting 
(Whatham et al., 2008). The cause of visual impairment in this case is more overt, 
since vitamin A plays a central role in phototransduction. Rhodopsin, the visual 
pigment in rod cells, is composed of a transmembrane opsin protein and 
retinaldehyde (vitamin A aldehyde). In the dark, retinaldehyde fits well with opsin 
as the 11-cis isomer. Upon absorption of a photon, there is rotation around the 11-
cis double bond, resulting in the all-trans retinaldehyde isomer that no longer fits 
well with opsin. Opsin then changes shape and activates a G-protein coupled 
cascade for hyperpolarization of the cell, eventually resulting in transmission of 
visual information through the retina. The only light dependent reaction for vision 
occurs at the outer segments of the photoreceptors with the help of vitamin A 
(Kandel et al., 2000). Deficiency in vitamin A directly affects the formation of 
rhodopsin and phototransduction, thus resulting in vision problems.  
Deficiency in other vitamins affects the eye in less obvious mechanisms. In 
the case of vitamin E deficiency, the accumulation of lipofuscin granules 
 5 
(remnants of lipid and fatty acid oxidation) in the RPE seems to disrupt the outer 
segments of the rods and cones of the retina, eventually killing them (Robison et 
al., 1979, 1980). The spinal cord, cerebellum, and muscles (skeletal and cardiac) 
are also adversely affected (Kumar, 2010). In the retina, vitamin E is most 
concentrated in the outer segments of the photoreceptors and is believed to protect 
the cell membranes from free radical damage (Katz et al., 1978, Keys et al., 1997, 
Brigelius-Flohe and Traber, 1999). Though not directly involved in the visual 
process like vitamin A, vitamin E is critical for maintaining photoreceptor health 
and integrity – loss of the rods and cones leaves the retina without any light-
sensitive cells, leading to blindness. Finally, vitamin B12 deficiency is known to 
lead to optic neuropathy with centrocaecal scotoma (Cohen, 1936, Larner, 2004), 
amongst its hematological, neurological, and neuropsychological manifestations 
(Oh and Brown, 2003). The mechanism for this neuropathy is not well understood. 
 
1.3 Vitamin B12  
Vitamin B12 is a water-soluble vitamin, composed mainly of a planar corrin 
ring co-ordinating a central cobalt ion (Co+, Co2+, or Co3+) and a nucleotide 
substituent (5,6-dimethylbenzimidazole, also co-ordinated to the cobalt ion) 
(Hodgkin et al., 1956, Hodgkin, 1958). This basic structure is often referred to as a 
cobalamin (Figure 1); different derivatives of vitamin B12 are possible through 
variations of ligand attachments to the cobalt ion. For example, cyanocobalamin 
(CNCbl) has a cyanide ligand, while hydroxocobalamin (OHCbl), 
methylcobalamin (MeCbl), and 5’-deoxydenosylcobalamin (AdoCbl) have 
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hydroxyl, methyl, and deoxyadenosyl ligands, respectively. The cobalt ion in 
CNCbl and OHCbl are typically trivalent (Co3+) and must be reduced to divalent 
(Co2+) or monvalent (Co+) forms for conversion to MeCbl and AdoCbl in cells. 
While certain bacteria are capable of synthesizing their own vitamin B12, humans 
must acquire it through diet, making it an essential micronutrient.  
 
 
 
 
 
 
 
 
Figure 1. Chemical structure of vitamin B12 (cobalamin). R can be methyl, 
deoxydenosyl, hydroxyl, or cyanide.  
 7 
Vitamin B12 is typically acquired through the diet from animal products 
(e.g. meat, eggs, fish, shellfish, and milk) (Herbert, 1988, Watanabe, 2007, 
Whatham et al., 2008). Certain edible algae (i.e. seaweed) also contain vitamin B12, 
but are inactive in mammals (Watanabe, 2007). Stomach pepsin and hydrochloric 
acid play an important role in separating vitamin B12 from food, allowing it to be 
bound by hepatocorrin for protection against degradation in the stomach’s acidic 
environment. Once in the duodenum, hepatocorrin is digested by pancreatic 
proteases and vitamin B12 is bound by intrinsic factor (Andres et al., 2004, Kumar, 
2010). The intrinsic factor-bound vitamin B12 then travels through the small 
intestine and is eventually absorbed by the distal ileum upon attachment to 
receptors located on the ileal mucosal cells (Andres et al., 2004, Watanabe, 2007). 
Once in the mucosal cells, vitamin B12 is bound and transported into cells by the 
transcobalamin proteins and circulated systemically through the hepatic portal 
system (Andres et al., 2004, Watanabe, 2007).   
Cyanocobalamin (CNCbl), the form of vitamin B12 most commonly used in 
supplements, needs to be converted to methylcobalamin (MeCbl) or 5’-
deoxydenosylcobalamin (AdoCbl) in the body for cell use (Oh and Brown, 2003, 
Andres et al., 2004).  MeCbl acts as a cofactor for methionine synthase in the 
cytoplasm, while AdoCbl is a cofactor for L-methylmalonyl Co-A mutase in the 
mitochondria (Figure 2). These enzymes are critical for amino acid synthesis and 
the citric acid cycle; deficiency in vitamin B12 results in enzymatic dysfunction 
and disruptions in cellular metabolism (Andres et al., 2004).  
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Figure 2. Metabolic co-factor roles of vitamin B12. 5’-deoxydenosylcobalamin 
(purple) is a cofactor for methylmalonyl-CoA mutase, which transforms 
methylmalonyl-CoA to succinyl-CoA. Succinyl-CoA is required for the 
tricarboxylic acid (TCA) cycle, an important metabolic step in the generation of 
energy. Methylcobalamin (green) is a cofactor for methionine synthase, which is 
involved in the synthesis of methionine from homocysteine and 5-
methyltetrahydrofolate (5-methyl-THF). TCA, tricarboxylic acid; AdoCbl, 5’-
deoxydenosylcobalamin; MeCbl, methylcobalamin; THF, tetrahydrofolate.  
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1.4 Vitamin B12 Deficiency 
The daily recommended allowance of vitamin B12 intake for adults is 2.4 
µg (Stabler and Allen, 2004). Vitamin B12 deficiency is often diagnosed based on 
blood serum levels of vitamin B12 below 150 pmol/L (200 pg/mL) in addition to 
hematologic, neurologic, or psychiatric symptoms (Oh and Brown, 2003). An 
estimated 20% of general population in developed countries is believed to be 
vitamin B12 deficient (Carmel, 2000, Dali-Youcef and Andres, 2009). In the 
elderly population (adults aged 65 and above), the prevalence of vitamin B12 
deficiency is around 12% for those in the community (Lindenbaum et al., 1994), 
which increases to 30-40% for sick or institutionalized individuals (van Asselt et 
al., 2000).  
Though often difficult to determine, vitamin B12 deficiency can arise from 
several different causes. In the elderly, the most common causes of vitamin B12 
deficiency include achlorhydria (low or absent stomach acid production), and 
atrophic gastritis (bacterial or autoimmune inflammation of gastric mucosa, 
resulting in impaired release of stomach acid, pepsin, and intrinsic factor; Carmel, 
1997, Hurwitz et al., 1997). Not surprisingly, prolonged proton-pump inhibitor use 
(Marcuard et al., 1994) and gastric surgery (Schilling et al., 1984, Sumner et al., 
1996) can also cause vitamin B12 deficiency . Other gastrointestinal causes for 
vitamin B12 malabsorption and deficiency include Heliobacter pylori infection 
(often associated with mucosal atrophy and achlorhydria), tropical sprue, diseases 
of the ileum, and parasitic infestation of tapeworms (e.g. Diphyllobothrium latum, 
which results in competition for vitamin B12 ; Kumar, 2010).  
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Any sort of hereditary genetic defect in any of the proteins involved in 
vitamin B12 absorption and transport (e.g. intrinsic factor or transcobalamins) will 
also cause malabsorption deficiency (Rosenblatt and Cooper, 1990). Strict 
vegetarians (i.e. vegans who do not consume any animal products) can also 
develop vitamin B12 deficiency over the course of several years. For the most part, 
indications of deficiency arising from malabsorption manifest in about 2-5 years 
since the liver stores 50% of available cobalamin while the rest goes towards other 
tissues. However, vitamin B12 deficiency as a result of nitrous oxide abuse (for its 
euphoriant properties) manifests more quickly. Nitrous oxide is used as an inhaled 
anaesthetic, commonly known as ‘laughing gas’. In cells, nitrous oxide renders 
MeCbl inactive by permanently oxidizing the central cobalt ion (Deacon et al., 
1978, Schilling, 1986, Marie et al., 2000). Symptoms of deficiency appear much 
quicker in this case due to direct inactivation of vitamin B12.  
The most common clinical symptoms (Table 1) of vitamin B12 deficiency 
include: haematological abnormalities such as megaloblastic anaemia (large 
dysfunctional red blood cells) and neurological disturbances such as degeneration 
or sclerosis of the spinal cord, peripheral nerves, or the optic nerve (Andres et al., 
2004). While there appears to be a higher incidence of vitamin B12 deficiency in 
patients with dementia, Alzheimer’s disease, Parkinson’s disease, and depression, 
the causal relationship is not entirely clear (Carmel, 2000). The mechanism for the 
adverse effects of vitamin B12 deficiency on the nervous system, most notably the 
optic nerve, has yet to be elucidated.  
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Table 1. Clinical Symptoms of Vitamin B12 Deficiency  
Frequency Hematologic Neurologic Other 
 
 
Frequent 
 Megaloblastic 
anaemia 
 Hypersegmantation 
of neutrophils 
 Spinal cord 
sclerosis 
 Peripheral 
neuropathy 
 Myleoneuropathy 
 Optic neuropathy 
 Fatigue 
 Loss of appetite 
 Atrophic 
glossitis 
 
Rare or  
Under 
Study 
 Thrombocytopenia 
 Neutropenia 
 Pancytopenia 
 Haemolytic 
anaemia  
 Encephalopathy 
 Dementia 
 Cognitive 
changes 
 Stroke 
 Mucocutaenous 
ulcers 
 Myocardial 
infarction 
 Hypofertility 
 
1.5 Superoxide Anion 
Superoxide anion is the free-radical product of the single-electron 
reduction of molecular oxygen (O2). Biologically, superoxide anion is generated in 
the mitochondria as a by-product of oxidative phosphorylation and is capable of 
wreaking havoc in cells by altering important cellular macromolecules (e.g. 
proteins and lipids) when produced in excess (Buetler et al., 2004). Our white 
blood cells deploy superoxide anion to combat invading pathogens; phagocytes in 
particular catalyze the production of large amounts of superoxide anion with the 
help of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (Badwey 
and Karnovsky, 1980). Under normal physiological circumstances, the enzyme 
superoxide dismutase (SOD) catalyzes the conversion of superoxide anion into 
oxygen and hydrogen peroxide – which is further broken down to water by 
catalases – to protect mitochondria and cells from constant oxidative damage. 
Humans have three different SOD enzymes in different cellular compartments, i.e. 
SOD-1 (cytoplasm), SOD-2 (mitochondria), and SOD-3 (extracellular matrix) 
(Tainer et al., 1983, Hart et al., 1999).  
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Our previous work has shown that a burst of superoxide anion is a critical 
signal for apoptosis in axotomized neurons (Nguyen et al., 2003, Lieven et al., 
2006, Kanamori et al., 2010a). We also found that post-axotomy cell death can be 
inhibited, both in vitro and in vivo, through exogenous delivery of pegylated-SOD 
(PEG-SOD) (Schlieve et al., 2006, Kanamori et al., 2010a). The neuroprotection 
conferred to axotomized neurons by PEG-SOD is presumed to occur through 
interference of superoxide signaling for apoptosis. However, the impracticality of 
attempting to deliver exogenous SOD as a therapy has necessitated the need 
investigate small molecules which also have superoxide scavenging abilities. We 
recently showed that the metallocorroles can scavenge superoxide anion and 
prevent neuronal cell death, much like SOD (Kanamori et al., 2010b). The 
metallocorroles are small tetrapyrrolic macrocycle molecules that hold a metallic 
ion in the porphyrin-like inner core (Figure 3) (Gross and Galili, 1999, Kanamori 
et al., 2010b). Upon closer inspection of the structural features of the 
metallocorroles and vitamin B12, it is apparent that they both have a corrin ring and 
metal ion as their core chemical structure.  
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Figure 3. Chemical structure of the metallocorroles. M can be iron (Fe3+), 
manganese (Mn3+), or gallium (Ga3+).  
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II. HYPOTHESIS AND OBJECTIVES 
 
The mechanism for vitamin B12 deficiency-induced optic neuropathy is not 
well understood. Vitamin B12 has recently been found to react specifically with 
superoxide anion at rates approaching that of SOD (7 x 108 M-1s-1, comparable to 
the SOD-catalyzed rate of 2 x 109 M-1s-1) (Suarez-Moreira et al., 2009). 
Additionally, vitamin B12 has been found to act as an intracellular antioxidant in 
cell culture (Birch et al., 2009) while conferring increased viability to human 
aortic endothelial cells subjected to superoxide-induced damage, suggesting that 
vitamin B12 may play an additional role beyond its known cofactor functions 
(Suarez-Moreira et al., 2009, Suarez-Moreira et al., 2011). 
Since the metallocorroles and vitamin B12 share a core structure, and both 
have been found to effectively scavenge superoxide anion, it is possible that the 
core corrin ring structure (and metal ion) plays a role in scavenging. Given that 1) 
superoxide anion is a key apoptotic signal in our axotomy model for optic 
neuropathy (Kanamori et al., 2010a) and 2) vitamin B12 appears to be capable of 
superoxide anion scavenging, it is possible that vitamin B12 has a role in cellular 
redox maintenance in addition to its traditional co-factor roles. To the best of our 
knowledge, the effect of vitamin B12 deficiency on neurons have yet to be explored, 
despite the clinical presentation of neurological symptoms in patients that are 
vitamin B12 deficient. We hypothesize that vitamin B12 is a neuronal SOD 
mimetic, which during deficiency results in an increased level of superoxide 
anion in the cell as SOD becomes overwhelmed. This high level of superoxide 
then becomes a misplaced signal that activates the cell death pathway. Besides 
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causing pathologies through enzymatic dysfunction when deficient, it is possible 
that vitamin B12’s novel function as an intracellular antioxidant can provide some 
insight into the unknown mechanism of vitamin B12 deficient-optic neuropathy. 
The objectives of this project are to determine whether CNCbl, the form of vitamin 
B12 most commonly used in supplements, can scavenge superoxide anion in 
neuronal cells and be neuroprotective in vitro and in vivo. This study aims to 
elucidate a potential mechanism for vitamin B12 deficient-optic neuropathy and 
potentially bring insight to other neurologic presentations of vitamin B12 
deficiency.  
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Abstract 
Damage to the optic nerve (optic neuropathy) can result in permanent loss 
of vision or blindness through retinal ganglion cell (RGC) death. Our prior 
work identified a burst of superoxide anion as a critical molecular event in 
RGCs prior to injury-induced cell death. Recently, Suarez-Moreira et al 
(JACS 131:15078, 2009) demonstrated that vitamin B12 scavenges 
superoxide as effectively as superoxide dismutase. Given that vitamin B12 
deficiency can lead to optic neuropathy through unknown mechanisms, we 
investigated the relationship between superoxide scavenging by 
cyanocobalamin, the most abundant vitamin B12 vitamer, and its 
neuroprotective properties in neuronal cells.  
 
Superoxide anion reacts with hydroethidine to produce a fluorescent 
product, 2-hydroxyethidium. Superoxide scavenging by cyanocobalamin in 
a cell-free system was measured with a fluorescent microplate reader. 
Superoxide scavenging in RGC-5 neuronal cells was assessed in vitro by 
fluorescent microscopy. Neuroprotection against menadione was 
evaluated by calcein-AM/propidium iodide assay to identify living and dead 
cells. An optic nerve transection model in Long-Evans rats was used to 
study superoxide scavenging and neuroprotection in vivo, with visualization 
of superoxide within retrograde-labelled RGCs by confocal scanning laser 
ophthalmoscopy.  
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Cyanocobalamin at concentrations of 10 µM and 100 µM reduced the rate 
of superoxide generation by 34% and 79% in cell free assays, respectively. 
In menadione-treated RGC-5 cells, cyanocobalamin concentrations above 
10 nM scavenged superoxide anion similar to those treated with pegylated-
SOD. Cyanocobalamin at concentrations of 100 µM and 1 mM reduced 
RGC-5 cell death from menadione by 20% and 32%, respectively. In rats 
with unilateral optic nerve transection, a single intravitreal dose of 667 µM 
cyanocobalamin significantly reduced the number of 2-hydroxyethidium–
positive RGCs. This dose also increased RGC survival rate compared to 
rats injected with saline control.  
These data suggest that vitamin B12 may be an endogenous 
neuroprotectant, which when depleted in nutritional deficiency, could cause 
death of retinal ganglion cells by a superoxide-dependent mechanism. 
Vitamin B12 could also potentially also be used as a therapy to slow 
progression of RGC death in patients with optic neuropathies characterized 
by overproduction of superoxide.  
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Introduction 
The optic nerve is responsible for relaying visual stimuli from the retina to 
the brain and is composed of retinal ganglion cell (RGC) axons. When the 
optic nerve is damaged from injury or disease (i.e. an optic neuropathy), 
the RGC soma activates a programmed cell death pathway and undergoes 
apoptosis, resulting in irreversible visual loss. Optic neuropathies are the 
leading cause of blindness worldwide, with glaucoma being the most 
prevalent of the optic neuropathies (Quigley, 1996). In the United States 
alone, an estimated 2.2 million people are currently affected by glaucoma 
(Quigley and Broman, 2006, Dirani et al., 2011), the prevalence of which is 
expected to increase as the population ages.  
 
Optic neuropathies arise from multiple etiologies, including intraocular 
pressure too high for the optic disc, ischemia (Selles-Navarro et al., 1996), 
tumors (Danesh-Meyer et al., 2008), infection (Trip et al., 2005), or trauma 
(Steinsapir, 1999). Although often overlooked, deficiencies of critical 
vitamins and nutrients can also lead to vision problems (Whatham et al., 
2008). Vitamin B12 deficiency in particular is known to lead to bilateral optic 
neuropathy, characterized by centrocecal scotomas and the slow 
development of optic atrophy (Cohen, 1936, Larner, 2004), in addition to 
more common hematological, neurological, and neuropsychological 
manifestations (Oh and Brown, 2003).  
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Vitamin B12 is an essential micronutrient acquired through the diet in 
animal products such as meat and eggs (Herbert, 1988, Watanabe, 2007, 
Whatham et al., 2008). Digestion of food by stomach pepsin and 
hydrochloric acid release vitamin B12 and allow it to be bound by intrinsic 
factor in the duodenum (Andres et al., 2004, Kumar, 2010). The intrinsic 
factor-bound vitamin B12 then travels through the small intestine and is 
eventually absorbed by the distal ileum upon attachment to receptors 
located on the ileal muscoal cells (Andres et al., 2004, Watanabe, 2007). 
Once in the mucosal cells, vitamin B12 is bound and transported into cells 
by transcobalamins and circulated systemically through the hepatic portal 
system (Andres et al., 2004, Watanabe, 2007). Cyanocobalamin, the form 
of vitamin B12 most commonly used in supplements, is converted to 
methylcobalamin (MeCbl) and 5’-deoxydenosylcobalamin (AdoCbl) (Oh 
and Brown, 2003, Andres et al., 2004). MeCbl acts as a cofactor for 
methionine synthase in the cytoplasm, while AdoCbl is a cofactor for L-
methylmalonyl Co-A mutase in mitochondria (Figure 1A). These enzymes 
are critical for amino acid synthesis and the citric acid cycle, with vitamin 
B12 deficiency resulting in enzymatic dysfunction and disrupted cellular 
metabolism (Andres et al., 2004).  
 
In contrast, the mechanism for vitamin B12 deficiency-induced optic 
neuropathy is not well understood. A possible mechanism for vitamin B12 
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deficiency-induced optic neuropathy involves the recent finding that vitamin 
B12 can act as an intracellular antioxidant (Birch et al., 2009). This suggests 
that vitamin B12 may play an additional role beyond its known cofactor 
functions (Figure 1B). Vitamin B12 reacts with superoxide anion at rates 
approaching that of superoxide dismutase, and protects human aortic 
endothelial cells from superoxide-induced damage (Suarez-Moreira et al., 
2009, Suarez-Moreira et al., 2011). Superoxide anion is produced as a 
byproduct of electron transport chain leakage, and normally is scavenged 
by superoxide dismutase (SOD), thereby protecting mitochondria from 
constant oxidative damage. However, there is another role for superoxide 
in the nervous system, namely as a signal for apoptosis in axotomized 
neurons (Nguyen et al., 2003, Lieven et al., 2006, Kanamori et al., 2010a). 
Cell death after axotomy can be inhibited through exogenous delivery of 
pegylated superoxide dismutase-1 (PEG-SOD) (Schlieve et al., 2006, 
Kanamori et al., 2010a), presumably by inhibiting superoxide signaling of 
apoptosis.  
 
The difficulties associated with delivering exogenous SOD therapeutically 
prompted the development of small molecules that scavenge superoxide. 
We recently showed that metallocorroles which scavenge superoxide 
anion (Eckshtain et al., 2009) can prevent neuronal cell death (Kanamori et 
al., 2010b). Metallocorroles are small tetrapyrrolic macrocycles that contain 
a metallic ion in the porphyrin-like inner core (Figure 1C) (Gross and Galili, 
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1999, Kanamori et al., 2010b). Metallocorroles and vitamin B12 both have a 
corrin ring as their core chemical structure (Figure 1C). The ability of these 
molecules to scavenge superoxide anion is likely related to this core corrin 
ring structure.  
 
Given that superoxide anion is a signal for signaling apoptosis after RGC 
axotomy (Kanamori et al., 2010a) and that vitamin B12 shares a core 
structure with superoxide-scavenging and neuroprotective metallocorroles, 
we hypothesized that vitamin B12 is an endogenous SOD mimetic which 
when deficient would lead to RGC death. The mechanism of RGC death in 
vitamin B12 deficiency would result from elevated levels of physiological 
superoxide, which would aberrantly signal a pathological cell death 
pathway meant for axonal injury. To explore this hypothesis, we studied 
the role of vitamin B12 as a superoxide scavenger and neuroprotectant in 
vitro and in vivo. 
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Materials and Methods 
Animals 
Female Long Evans rats weighing 225-250g were from Charles River, 
Canada. Rats were housed in the Maisonneuve-Rosemont Hospital 
Research Centre Animal Facility in a temperature-controlled environment 
with a 12-hour light/dark cycle. Food and water were provided ad libitum. 
Animals were anesthetized by intraperitoneal injection of ketamine (50 
mg/kg) and xylazine (100 mg/kg) prior to any surgery or imaging procedure. 
All animal experiments were carried out in accordance with the guidelines 
of the Maisonneuve-Rosemont Hospital Research Centre Animal Care 
Committee and the Canadian Council on Animal Care.  
Materials 
RGC-5 cells were a generous gift from Neeraj Agarwal, PhD. Dulbecco’s 
modified Eagle’s medium (DMEM), and fetal bovine serum were from 
Wisent Inc. (St. Bruno, QC). Staurosporine was from Alexis Biochemicals 
(San Diego, CA). Hydroethidine (dihydroethidium; HEt) was from Fluka 
BioChemika (Buchs, Switzerland). Penicillin-streptomycin, polyethlylene 
glycol conjugated to superoxide dismutase from bovine erythrocytes (PEG-
SOD), menadione, xanthine, and xanthine oxidase were from Sigma-
Aldrich (St. Louis, MO). Phosphate buffered saline (PBS) was from Lonza, 
Inc. (Walkersville, MD). Salmon sperm DNA, calcein AM, and propidium 
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iodide were from Invitrogen (Carlsbad, CA). 4-Di-10-Asp, [4-(4-
(didecylamino)styryl)-N-methylpyridinium iodide] was from Anaspec 
(Fremont, CA). Cyanocobalamin was from U.S Biological (Swampscott, 
MA).  
Cell-Free Assays 
Xanthine (100 µM) was mixed with HEt (100 µM), 1 mg/mL of salmon 
sperm DNA, and 100 pM – 100 µM of cyanocobalamin. This master mix 
was incubated in quadruplicate in a black 96-well plate (Nunc, Rochester, 
NY), and xanthine oxidase (5 mU/mL) was added last to initiate 
superoxide-generation. Plates were read in a CytoFluor 4000 (Perseptive 
Biosystems, Framingham, MA) fluorescent plate reader every ten minutes 
for an hour at 360±40 nm excitation and 580±50 nm emission. 
Cell Culture 
RGC-5 cells were cultured in DMEM containing 1 g/L glucose, 
supplemented with 10% fetal bovine serum, 100 U/mL penicillin, and 100 
µg/mL streptomycin. Cells were split every 48 to 72 hours when cells were 
approximately 60-85% confluent, re-plated at a 1:20 dilution in a 25 cm2 
flask in 5 mL of cell culture media and incubated at 37°C in humidified 5% 
CO2. Cells were seeded into 6-well culture plates (Sarstedt, Nümbrecht, 
Germany) for all in vitro experiments. For studies using differentiated RGC-
5 cells, cells were incubated in media containing 316 nM staurosporine for 
3 hours to allow cells to differentiate before further treatments. This 
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concentration resulted in minimal cell death when early passages (7-15) 
were used. All experiments were performed in triplicate.  
Measurement of intracellular superoxide in vitro 
Differentiated RGC-5 cells were treated with media containing 15 µM 
menadione to generate superoxide and treated with various scavengers for 
24 hours. Cells were then stained with HEt (50 µM) for 30 minutes before 
rinsing with PBS for quantitative epifluorescence microscopy (excitation 
395 ± 5.5 nm, 500 nm dichroic, emission 560 ± 20 nm; Zeiss Axio 
Observer A1). Microscope fields were randomly sampled and all photos 
were taken at the same exposure settings. ImageJ (National Institutes of 
Health, Bethesda, MD) was used for image analysis of the HEt 
fluorescence signal from cells, as previously described (Kanamori et al., 
2010b).  
Fluorescent live-dead assays 
No. 1 glass coverslips (VWR, Radnor, PA) were sterilized by flaming in 
absolute ethanol prior to coating with poly-L-lysine (Sigma-Aldrich, St. 
Louis, MO). RGC-5 cells were seeded onto the glass coverslips in 6-well 
tissue culture plates (Sarstedt, Nümbrecht, Germany). After differentiation, 
cells were treated with various agents for 24 hours. Cells were then stained 
with calcein-AM (1 µM) and propidium iodide (PI; 5 µM) in PBS for 20 
minutes at 37°C in humidified 5% CO2. Coverslips were rinsed in PBS and 
fixed in 4% paraformaldehyde for 30 minutes before rinsing 3 times (15 
minutes each) with PBS. Coverslips were mounted on glass slides using 
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PermaFluor (Thermo Scientific, Walthan, MA) for epifluorescence 
microphotography (Zeiss Axio A1). Four random microscope fields were 
captured for each coverslip for analysis. An observer masked to treatment 
groups manually counted the number of live (calcein-positive) and dead 
(PI-positive) cells in each microphotograph.  
Retrograde labelling of RGCs 
RGCs were retrogradely labeled by stereotactic injection of 4-Di-10-Asp 
into both superior colliculi, as previously described (Kanamori et al., 2010a). 
Briefly, anesthetized rats were placed in a stereotactic apparatus and the 
cortex surface was exposed by drilling the parietal bone to facilitate dye 
injection. A total volume of 2.8 µL of 100 mM 4-Di-10-Asp was injected 
bilaterally at 6 mm caudal to bregma and 1.2 mm lateral to the midline to a 
depth of 4.5 mm from the skull surface. Animals were maintained for 4-7 
days after 4-Di-10-Asp injection into the superior colliculi to ensure dye 
transport to RGC somas. 
Optic nerve transection 
After RGC labeling, intrameningeal optic nerve transection on the right eye 
was performed as previously described (Kanamori et al., 2010a). The left 
eye served as an untransected control. All animals were examined by 
indirect ophthalmoscopy after optic nerve transection to ensure the 
integrity of the retinal blood supply. Rats with abnormal retinal vessels or 
retinal edema were not used further. 
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Intravitreal injections 
Intravitreal injections of HEt and CNCbl were performed as previously 
described (Kanamori et al., 2010b). Briefly, injections were made 
immediately posterior to the superotemporal limbus at a 45° angle using a 
32-gauge needle attached to a 10 µL Hamilton syringe (Hamilton, Reno, 
NV). Figures 4A and 4D show the different injection time points relative to 
transection and imaging for different experiments.  
In vivo confocal laser scanning ophthalmoscopy 
A Heidelberg Retinal Angiogram 2 (Heidelberg Engineering, Germany) 
confocal scanning laser ophthalmoscope (CSLO) was used for in vivo 
imaging of the rat retina, as previously described (Kanamori et al., 2010a). 
Briefly, rats were anesthetized and their pupils dilated with phenylephrine 
and atropine. The 488 nm laser was used for the excitation of OH-Et 
positive cells and 4-Di-10-Asp retrograde-labeled RGC somas. To ensure 
the plane of focus was in the ganglion cell layer, the CSLO polarization 
filter (red-free mode) was used to focus onto the nerve fiber layer and then 
adjusted posteriorly. Retinal images were captured using a 30° field of view 
lens with real-time averaging of at least 50 images. The same four retinal 
quadrants (superior, inferior, nasal, and temporal) immediately adjacent to 
the optic nerve were imaged over time in each rat. OH-Et positive cells or 
4-Di-10-Asp-labeled cells within specific retinal sections of each image 
outlined by major retinal blood vessels were counted by an observer 
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masked to the treatment group, for quantification of superoxide production 
or neuroprotection, respectively.  
Statistics 
Statistical analysis was done using Prism v.5.0 (Graphpad Software Inc., San 
Diego, CA). Unpaired t-tests were used to compare means from two groups, 
with α = 0.05. For comparisons between multiple groups, significance was 
calculated using one-way analysis of variance (ANOVA) followed by Dunnett’s 
Multiple Comparison post-hoc test at α = 0.05 against the negative control 
group. Data are presented as mean ± SEM unless otherwise indicated.  
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Results 
Cyanocobalamin scavenges superoxide in a cell-free system 
We measured the relative fluorescence units (RFU) of the reaction 
between superoxide and HEt to determine the degree of superoxide 
scavenging by CNCbl compared to SOD. HEt is the non-fluorescent 
reduced form of ethidium (Zhao et al., 2003). Upon reacting with 
superoxide, HEt oxidizes to 2-hydroxyethidium (OH-Et) and binds to DNA 
to yield a fluorescent signal (excitation 395 nm, emission 567 nm; Figure 
2A and 2B). The reaction approaches maximal fluorescence at 30 minutes 
(Figure 2C). In order to compare scavenging with CNCbl (100 pM – 100 
µM) or bovine erythrocyte SOD (0.36 U/mL), we calculated the slope from 
the first 30 minutes of each reaction and compared the rate (RFU/minute) 
of superoxide production in the presence or absence of scavenger. 
Numerically larger slopes indicated more superoxide reacting with HEt to 
yield fluorescent OH-Et, i.e. less superoxide scavenging, while smaller 
slopes indicated greater scavenging. The slope with the positive control 
SOD was significantly less than the no-scavenger control (0.29 ± 0.018 vs. 
1.65 ± 0.049 RFU/min; p < 0.0001), and indicated scavenging of 82% of 
available superoxide. The slopes with CNCbl (10 µM or 100 µM) were also 
significantly less than the no-scavenger control (1.09 ± 0.030 and 0.34 ± 
0.0058 RFU/min; p < 0.0001 for both comparisons), and indicated 
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scavenging of 34% and 79% of available superoxide, respectively (Figure 
2D).  
Cyanocobalamin scavenges superoxide in vitro in neuronal cells 
Differentiated RGC-5 cells were treated with menadione to generate 
intracellular superoxide anion via mitochondrial redox cycling (Nguyen et 
al., 2003). HEt can passively diffuse across the plasma membrane of live 
cells to react with intracellular superoxide, followed by binding to nuclear 
DNA and thereby yielding a fluorescent signal in the nucleus. 
Quantification of the nuclear fluorescence therefore is an indirect measure 
of superoxide levels (Figure 3A). Compared to cells exposed to menadione 
in the absence of a scavenger, cells treated with CNCbl concentrations 
from 1 nM to 1 mM had significantly decreased levels of superoxide 
(Figure 3B). Superoxide levels of menadione-treated RGC-5 cells 
decreased in the presence of CNCbl, with 20% scavenging at 1 nM and 
42% scavenging at 1 µM. Higher concentrations of CNCbl did not 
demonstrate greater superoxide scavenging.  
Cyanocobalamin increases cell survival in vitro in neuronal cells 
Differentiated RGC-5 cells were treated with menadione (15 µM) to 
generate superoxide in the presence or absence of CNCbl (1 pM to 1 mM) 
or PEG-SOD (30 U/mL) as a positive control, then stained with calcein-AM 
and PI to assess cell survival (Figure 3C). Cells exposed to menadione in 
the absence of a CNCbl or PEG-SOD had a mean 21.2 ± 8.8% survival 
(Figure 3D). RGC-5 survival increased significantly in the presence of as 
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little as 10 pM CNCbl (56.5 ± 3.58%; p < 0.001 compared to control), and 
was 87.7 ± 3.44% (p < 0.0001) with 10 µM CNCbl. Higher concentrations 
of CNCbl resulted in RGC-5 cell survival comparable to cells treated with 
PEG-SOD.  
Cyanocobalamin scavenges superoxide in retinal ganglion cells in 
vivo after optic nerve transection 
In order to determine whether vitamin B12 was a superoxide scavenger in 
vivo, we took advantage of our ability to use confocal scanning laser 
ophthalmoscopy to longitudinally image superoxide in axotomized rat 
RGCs (Kanamori et al., 2010a, Kanamori et al., 2010b). HEt was injected 
into the vitreous 3 days after optic nerve transection in Long Evans rats in 
the presence or absence of CNCbl, using four injection paradigms with 
different concentrations and timing of administration (Figure 4A). Injecting 
a high CNCbl dose (667 µM) sooner after transection decreased the 
number of superoxide-positive cells (44.2 ± 6.1 vs. 77.3 ± 7.4 in the no 
CNCbl control; 39% decrease; p = 0.003). A lower CNCbl dose (333 µM) 
injected later after transection non-significantly decreased the number of 
superoxide-positive cells (71.4 ± 6.2; 7.6% decrease; p = 0.51). The 
greatest decrease (34.7 ± 3.8; 55% decrease; p < 0.0001) in superoxide-
positive cells after axotomy occurred when an initial 667 µM CNCbl dose 
was followed by a delayed 333 µM CNCbl dose (Figure 4B, 4C).  
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Cyanocobalamin increases cell survival of retinal ganglion cells in 
vivo after optic nerve transection 
RGCc were retrograde labeled by injection of 4-Di-10-Asp into the superior 
colliculi 4-7 days prior to optic nerve transection (Figure 4D). Rats received 
an intravitreal injection of 667 µM CNCbl or vehicle control one day after 
transection and were longitudinally imaged by CSLO to monitor RGC 
survival (Figure 4E). At 5 days post-transection, rats that received an 
intravitreal injection of 667 µM CNCbl had 87.0 ± 2.62% RGC survival 
compared to the vehicle control (69.0 ± 3.66 %; p = 0.0008). At 7 days 
post-transection, CNCbl-treated retinas had a 79.7 ± 2.47% RGC survival 
compared to the vehicle control animals (53.1 ± 2.30%; p < 0.0001;). 
Finally, at 14 days post-transection, CNCbl-treated retinas had 59.7 ± 
3.28% RGC survivial compared to those that received vehicle control (29.3 
± 2.32; p < 0.0001, Figure 4F) 
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Discussion 
These data demonstrate that (1) CNCbl scavenges superoxide anion 
generated in a cell-free reaction between xanthine and xanthine oxidase; 
(2) CNCbl scavenges intracellular superoxide induced by menadione-
induced redox cycling, and protects against cell death in vitro; and (3) 
CNCbl scavenges superoxide and is neuroprotective in vivo in rat RGCs 
after optic nerve transection. To the best of our knowledge, this is the first 
demonstration that CNCbl scavenges superoxide and is neuroprotective in 
neuronal cells in vitro and in vivo. 
 
Previous reaction kinetic studies have shown that vitamin B12 reacts with 
superoxide in a second order reaction to generate H2O2 at a rate of 7 x 108 
M-1s-1, which is comparable to the SOD-catalyzed rate of 2 x 109 M-1s-1 
(Suarez-Moreira et al., 2009). The same group also demonstrated in vitro 
superoxide scavenging by CNCbl in an endothelial cell line. Clinically, 
patients with genetic vitamin B12 metabolism disorders have significantly 
greater levels of markers for oxidative stress in their urine (Mc Guire et al., 
2009), possibly due to the lack of superoxide scavenging by vitamin B12. 
Together with the results from our study demonstrating that vitamin B12 
scavenges superoxide and is neuroprotective in neuronal cells, these 
findings suggest that vitamin B12 contributes to the maintenance of cellular 
 36 
redox status, in addition to its several known functions as a co-factor in 
metabolic processes.  
 
Such findings provide a pathophysiological explanation for an uncommon 
but potentially devastating disease, the optic neuropathy caused by vitamin 
B12 deficiency. This deficiency has well-known neurological manifestations, 
with peripheral neuropathy, subacute combined (posterior and lateral 
columns) degeneration of the spinal cord, cognitive changes, and optic 
neuropathy being the most prominent. The damage from vitamin B12 
deficiency within the retina is specific to RGCs, and spares photoreceptors 
and other retinal neurons on clinical and pathological grounds (Chester et 
al., 1980). Therefore, a unifying explanation for the pathophysiology of 
vitamin B12 deficiency in the eye necessarily has to include why it is 
restricted to the RGC. It cannot be mitochondrial stress or insufficient 
production of ATP, because genetic mitochondrial diseases such as 
mitochondrial DNA (mtDNA) deletions, mitochondrial encephalomyopathy, 
lactic acidosis, and stroke-like episodes (MELAS), and neuropathy, ataxia 
and retinitis pigmentosa (NARP) affect high energy-consuming tissues (e.g. 
skeletal muscle and photoreceptors), but not RGCs. 
 
Based on the results of the present study, we instead propose that the 
specificity of vitamin B12 deficiency for RGCs is because (1) this molecule 
is a superoxide scavenger within RGCs, and (2) RGCs are particularly 
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sensitive to superoxide-induced cell death. We know from our previous 
studies (Lieven et al., 2006, Kanamori et al., 2010a) that RGCs use 
superoxide as an intracellular signaling molecule to transduce apoptosis 
after axonal injury. Drugs that scavenge superoxide decrease RGC death 
(Kanamori et al., 2010a, Kanamori et al., 2010b, Catrinescu et al., 2012), 
while induction of elevated superoxide by knockdown of superoxide 
dismutase isoforms induces neuronal or RGC death (Scott et al., 2010, 
Yuki et al., 2011). Given our results in the present study demonstrating that 
vitamin B12 is a neuronal superoxide scavenger in vitro and in vivo, coupled 
with previous studies demonstrating that elevated superoxide is an 
axotomy signal and induces RGC death, then it follows that vitamin B12 
deficiency would lead to dysregulated superoxide levels and consequent 
RGC death, i.e. optic neuropathy.  
 
RGCs, like all cells, contain superoxide dismutase-1 (SOD-1) in the 
cytoplasm and SOD-2 in the mitochondria. These endogenous superoxide 
scavengers would have to be overwhelmed in vitamin B12 deficiency, which 
would occur in situations where there was high levels of mitochondrial 
oxygen consumption and consequent superoxide leak from the 
mitochondrial electron transport chain (Kussmaul and Hirst, 2006). RGCs 
have high numbers of mitochondria in the unmyelinated portion of their 
axons, particularly at the optic nerve head anterior to the myelin transition 
zone (Waxman, 1978, Carelli et al., 2004). More mitochondria are need in 
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unmyelinated than myelinated axons because the lower membrane 
resistance and higher capacitance necessitates larger current flux for 
axonal conduction. Therefore, the prelaminar and laminar portion of the 
optic nerve head is a putative hot spot for superoxide-mediated damage 
resulting from vitamin B12 deficiency. 
 
Support for a superoxide-dependent mechanism comes from a seemingly 
unrelated optic neuropathy, Leber hereditary optic neuropathy (LHON), 
which shares with vitamin B12 deficiency neuropathy an uncommon clinical 
phenotype, a cecocentral scotoma visual field defect (Newman et al., 
2006). This maternally inherited optic neuropathy results from one of three 
mutations in mtDNA coding for subunits of complex I of the mitochondrial 
electron transport chain, and causes relatively specific damage to RGCs, 
with minimal effects elsewhere in the retina, CNS, or body (Kerrison and 
Newman, 1997). The LHON mutations do not significantly decrease ATP 
production in studies of fibroblast cybrids (Baracca et al., 2005). However, 
they greatly increase superoxide levels, and it is more likely that the 
superoxide induction is responsible for the the RGC-specific death in 
LHON (Levin, 2007). 
 
There are several potential weaknesses in our study. We used RGC-5 
cells for our in vitro studies, which are neuron-like but not actually RGCs 
(Van Bergen et al., 2009, Wood et al., 2010, Nieto et al., 2011). However, 
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the in vivo studies were with RGCs, thus making this less of a concern. We 
used an optic nerve transection model in rats to investigate whether CNCbl 
can scavenge superoxide and increase cell survival in vivo, with the added 
advantage of monitoring how transected RGCs respond to intravitreal 
injections of CNCbl in the same animal over time. Optic nerve transection 
is an acute injury, and models diseases like traumatic optic neuropathy, 
which is far less common than other optic nerve disease such as glaucoma. 
Finally, our focus on the optic nerve is not necessarily extrapolable to the 
spinal cord, peripheral nerves, and the cerebral cortex, which are also 
affected by vitamin B12 deficiency. 
 
In summary, CNCbl scavenges superoxide anion and is neuroprotective for 
RGCs after axonal injury in vivo. These results extend previous studies 
(Birch et al., 2009, Suarez-Moreira et al., 2009, Suarez-Moreira et al., 2011) 
demonstrating a novel role for vitamin B12 in maintaining cellular redox 
status, and support the hypothesis that vitamin B12 deficiency optic 
neuropathy results from a misplaced signal for cell death due to 
unconstrained superoxide generation. These results also have implications 
for the ocular health of populations at risk of vitamin B12 deficiency, most 
notably the elderly, vegans, and third world populations. Further study 
examining the prevalence of vitamin B12 deficiency in patients with optic 
neuropathies could prove informative for implementing preventative 
therapy for high risk populations.  
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Figure Legends 
Figure 1. Association of vitamin B12 deficiency and optic neuropathy. 
(A) Vitamin B12 derivatives methylcobalamin (MeCbl) and 
5’deoxyadenosylcobalamin (AdoCbl) are cofactors involved in methionine 
synthesis and propionate metabolism respectively. AdoCbl is required for 
the conversion of methylmalonyl-CoA to succinyl-CoA, an intermediate in 
the tricarboxylic acid (TCA) cycle.  (B) Cobalamin has been shown to 
scavenge superoxide anion. Scavenging equation re-written from Suarez-
Moreira et al. 2009, JACS 141(42): 15078 . (C) Chemical structures of 
cobalamin (left) and metallocorrole (right). R can be methyl 
(methylcobalamin), hydroxyl (hydroxocobalamin), deoxyadenosyl 
(5’deoxyadenosylcobalamin), or cyanide (cyanocobalamin). M can be iron 
(Fe3+), manganese (Mn3+), or gallium (Ga3+). Both structures contain a 
corrin ring (red circle), which could underlie the superoxide scavenging 
properties of these compounds.  
 
Figure 2. Vitamin B12 scavenges superoxide anion in a cell-free 
system. (A) Chemical structure of hydroethidine (HEt), ethidium (Et), and 
2-hydroxyethidium (OH-Et). Et is the fluorescent product of HEt’s single 
electron reaction while OH-Et is the production of HEt’s reaction with 
superoxide anion. (B) Excitation and emission spectra of Et (purple) and 
OH-Et (green) at 510 nm and 396 nm excitation, redrawn from Kanamori et 
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al. 2010, Brain 133(9): 2612-2625.  (C) Curve graph of OH-Et generation 
over time. (D) Bar graph of slopes from Figure 2C. A greater slope 
indicates less superoxide scavenging.  
 
Figure 3. Vitamin B12 scavenges superoxide and is neuroprotective in 
vitro in menadione-treated RGC-5 cells. Differentiated RGC-5 cells were 
treated with 15 uM menadione for 24 hours in the presence or absence of 
cyanocobalamin. (A) Representative microscope photos of HEt-stained 
RGC-5 cells. Fluorescence is localized in the nucleus (B) Bar graph 
summarizing OH-Et levels of RGC-5 cells. CNCbl concentrations greater 
than 1 µM do not demonstrate greater superoxide scavenging. (C) 
Representative microscope photos of RGC-5 cells stained with calcein 
(green) and PI (red). (D) Bar graph summarizing the percentage of RGC-5 
cell survival.   
 
Figure 4. Vitamin B12 scavenges superoxide and is neuroprotective in 
vivo in rats with unilateral optic nerve transection. (A) Flowchart of 
experimental paradigms. Day 0 (D0) marks the day of transection (ONT). 
HEt (100 µM) was injected intravitreally 3 days post-transection. CSLO 
imaging was performed 4 days post-transection, based on previous studies 
demonstrating that transected RGCs yield maximal OH-Et staining at that 
time (Kanamori et al., 2010a). (B) Representative CSLO images of OH-Et-
positive cells. Retinas treated with CNCbl appear to have less OH-Et 
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positive cells compared to those treated with vehicle control. (C) Bar graph 
summerizing number of OH-Et positive cells with respect to CNCbl 
treatment. (D) Flowchart of experimental paradigm for determining in vivo 
neuroprotection. RGCs were retrogradely labelled (-D5) with 4-Di-10-Asp 
prior to transection (D0). Rats received an intravitreal injection of 667 µM  
CNCbl (D1) and imaged on 5, 7, and 14 days post-transection. (E) 
Representative CSLO images of labelled RGCs treated with CNCbl or 
vehicle control prior to transction and at 5 and 7 days post-transection. (F) 
Bar graph summerizing percentage of RGC survival at 5, 7, and 14 days 
post-transection when treated with CNCbl (blue) or vehicle control (yellow).  
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Figure 1. Association of vitamin B12 deficiency and optic neuropathy. 
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Figure 2. Vitamin B12 scavenges superoxide anion in a cell-free 
system. 
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Figure 3. Vitamin B12 scavenges superoxide and is neuroprotective in 
vitro in menadione-treated RGC-5 cells. 
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Figure 4. Vitamin B12 scavenges superoxide and is neuroprotective in 
vivo in rats with unilateral optic nerve transection 
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IV. DISCUSSION 
 
4.1 Summary of Experimental Results 
The results demonstrate that (i) CNCbl can scavenge superoxide anion 
generated in a cell free reaction between xanthine and xanthine oxidase; (ii) 
CNCbl is effective at scavenging superoxide produced by menadione-induced 
redox cycling and is also neuroprotective in vitro in RGC-5 neuronal cells exposed 
to excess superoxide; (iii) CNCbl is effective at scavenging superoxide and is 
neuroprotective in vivo in rat RGCs when CNCbl is injected into eyes that have 
undergone optic nerve transection.  
 
4.2 Justification of Methods 
Dihydroethidine (HEt) has two oxidation products (Figure 1): ethidium 
(Et), the single electron oxidation product of HEt, and 2-hydroxyethidium (OH-Et), 
the oxidation product of superoxide anion and HEt (Robinson et al., 2006). The 
emission spectra of OH-Et and Et overlap when excited at 560 nm (Robinson et al., 
2006). However, OH-Et has a distinct excitation spectrum around 396 nm. Thus, 
to minimize excitation of both OH-Et and Et, we excited OH-Et more specifically 
using shorter wavelength light, with an excitation wavelength of 360 ± 40 nm for 
the cell-free experiments, 395 ± 5.5 nm for the in vitro superoxide anion 
experiments (epifluorescence microscopy of live cells), and 488 nm for the in vivo 
experiments (confocal laser scanning ophthalmoscopy; CSLO). While Et can also 
be partially excited at 488 nm, we have previously confirmed through 
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epifluorescent microscopy (395 ± 5.5 nm excitation) that the fluorescence detected 
in vivo by the CSLO is OH-Et (Kanamori et al., 2010a).  
 
 
 
 
Figure 1. Chemical structures of dihydroethidium (HEt) oxidation products. 
Oxidation occurs in a two step fashion, involving formation of a HEt radical prior 
to further oxidation. Ethidium (Et) is the single electron oxidation product, while 
2-hydroxyethidium (OH-Et) is the superoxide anion oxidation product. Redrawn 
from Kanamori, A, et al. (2010). Brain 133(9): 2612-2625.  
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The cell type and origin of the RGC-5 cells used in our in vitro studies are 
controversial (Van Bergen et al., 2009, Wood et al., 2010, Nieto et al., 2011). 
When differentiated with 316 nM staurosporine for 3-4 hours, RGC-5 cells stop 
dividing, extend neurites, and express ion channels, all of which are characteristic 
of neuronal cells (Frassetto et al., 2006). RGC-5 cells and cells of the mouse cone 
photoreceptor line 661W differentiate almost identically (Thompson et al, 
unpublished data), consistent with the RGC-5 cell line being of retinal neuronal 
origin. Given that the goal of our in vitro model was to demonstrate whether 
CNCbl could scavenge superoxide and be neuroprotective for retinal neuronal 
cells, then the use of RGC-5 cells for in vitro studies was acceptable for 
preliminary experiments to determine the effects of vitamin B12 on neurons before 
proceeding with in vivo experiments.  
Our optic nerve transection model in rats allows us to investigate whether 
CNCbl can scavenge superoxide and increase cell survival in vivo, with the added 
advantage of monitoring how transected RGCs respond to intravitreal injections of 
CNCbl in the same animal over time. We recognize that the axotomized RGC 
axons in this model are more representative of traumatic optic neuropathies than 
more slowly progressing neuropathies like glaucoma. However, all optic 
neuropathies, regardless of etiology, result in the eventual death of RGCs. 
Therefore using an acute injury model is appropriate, given that the goal of the 
study was to investigate the superoxide scavenging and neuroprotective properties 
of CNCbl. Studies in an experimental glaucoma model would be useful for 
confirming the present results. 
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The results from this study also apply primarily to the optic nerve and 
cannot necessarily be generalized to the spinal cord, peripheral nerves, or the brain, 
which are also affected by vitamin B12 deficiency. The results presented in this 
thesis are from laboratory experiments in a cell line and an animal model, and 
cannot be simply extrapolated to human patients. Further research on the effects of 
CNCbl in models of spinal cord, peripheral nerve, and cortical degeneration would 
provide greater insight into vitamin B12’s role in different neurons.  
 
4.3 General Discussion 
Previous reaction kinetic studies have shown that vitamin B12 reacts with 
superoxide as a second order reaction to generate H2O2 at a rate of 7 x 108 M-1s-1, 
which is comparable to the SOD-catalyzed rate of 2 x 109 M-1s-1 (Suarez-Moreira 
et al., 2009). This group also demonstrated in vitro superoxide scavenging by 
CNCbl in a human aortic endothelial cell line. Clinically, patients with genetic 
vitamin B12 metabolism disorders have been found to have significantly greater 
levels of markers for oxidative stress in their urine (Mc Guire et al., 2009), likely 
due to the lack of critical superoxide scavenging by vitamin B12.  Furthermore, 
patients with chronic inflammatory diseases (Crocket, 1957, Flynn et al., 1994) 
and viral-induced inflammation (Wheatley, 2006) (both associated with oxidative 
stress) appear to benefit from vitamin B12 supplementation. Together with the 
findings from this study, vitamin B12 appears to play a role in the maintenance of 
cellular redox in addition to its known functions as a metabolic co-factor.  
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The mechanism of superoxide apoptotic signaling in vitamin B12 
deficiency-optic neuropathy is not well understood. However, there appears to be a 
relationship between vitamin B12, superoxide anion, and tumor necrosis factor 
(TNF-α). TNF-α is a cytokine mostly known for its role in the innate immune 
response and inflammation. Upon binding to either of its two receptors (TNFR1 or 
TNFR2), TNF-α can activate pathways involved in triggering an inflammatory 
response (activation of NF-κB pathway), cell proliferation or death in response to 
environmental stress (JNK pathway), or apoptosis through activation of caspases 
(Boldin et al., 1996, Hsu et al., 1996). Vitamin B12 has been found to mediate a 
balance between TNF-α and epidermal growth factor (EGF) in neurons through an 
unknown mechanism (Scalabrino, 2001, Miller, 2002). Clinically, patients with 
vitamin B12 deficiency have high levels of TNF-α in their cerebrospinal fluid 
compared to non-deficient control patients (Scalabrino et al., 2004). High levels of 
TNF-α in the aqueous humour of glaucoma patients have been reported (Balaiya et 
al., 2011). TNF-α and TNFR1 also appear to be upregulated in human 
glaucomatous optic nerve heads in parallel with the degree of optic nerve 
degeneration (Yuan and Neufeld, 2000). Experimentally, it was recently found that 
intravitreal injections of TNF-α lead to RGC cell death and optic nerve 
degeneration (Nakazawa et al., 2006, Lebrun-Julien et al., 2010).  
It is possible that vitamin B12 mediates TNF-α through a superoxide-
dependent pathway (Figure 2). Overexpression of SOD is known to inhibit 
apoptosis and render cells impervious to the cytotoxic effects of TNF-α (Afonso et 
al., 2006). One potential mechanism involves superoxide signaling TNF-α for 
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apoptosis when vitamin B12 is deficient, based on the recent findings that 
superoxide is an important molecule for TNF-α induction in microglia cells 
(Yoshino et al., 2011). Whether TNF-α is released predominately from retinal glia 
or neuronal cells in vitamin B12 deficiency is worth exploring, and further research 
would elucidate the cellular and molecular relationship between vitamin B12, 
superoxide anion, and TNF-α.  
 
 
Figure 2. Potential relationship between vitamin B12, superoxide anion, and 
tumour necrosis factor alpha (TNF-α). It is possible that increased superoxide 
anion production due to vitamin B12 deficiency signals TNF-α, which will then 
signal for apoptosis. It is unknown whether TNF-α is coming from the retinal 
neuronal cells or retinal glia. 
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V. CONCLUSION 
 
Our data show that CNCbl, the form of vitamin B12 most commonly use in 
supplements, can scavenge superoxide anion and be neuroprotective for RGCs. 
These results corroborate previous studies demonstrating a novel role for vitamin 
B12 in maintaining cellular redox status, and support the hypothesis that optic 
neuropathies in patients with vitamin B12 deficiency may result from a misplaced 
signal for cell death from excess superoxide generation. Our results have important 
implications for the ocular health of populations at risk of vitamin B12 deficiency, 
most notably the elderly, vegans, and third world populations. Further study 
examining the prevalence of vitamin B12 deficiency in patients with optic 
neuropathies could prove informative for implementing preventative therapy for 
high risk populations.  
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